Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometry

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Zixin ^a   Guo, Weixing ^a   Zhang, Dandan ^b   Pang, Yanan ^b   Shi, Jie ^a   Wan, Siqin ^a   Cheng, Kai ^b   Wang, Jiaqi ^b   Cheng, Shuqun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MORTALITY; SURVIVAL RATE; TUMOR EMBOLISM; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC CELLS, CIRCULATING; SURVIVAL RATE;

EID: 85007049612     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39808     Document Type: Article

References (16)

1. Krebs, M. G. et al. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat. Rev. Clin. Oncol. 11, 129-144 (2014).
2. Alix-Panabieres, C. & Pantel, K. Circulating tumor cells: liquid biopsy of cancer. Clin. Chem. 59, 110-118 (2013).
3. Zhang, Y. et al. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. Sem. Oncol. 39, 449-460 (2012).
4. Yu, M. et al. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 192, 373-382 (2011).
5. Alix-Panabieres, C. & Pantel, K. Challenges in circulating tumour cell research. Nat. Rev. Cancer. 14, 623-631 (2014).
6. Reyes, E. E. et al. Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer. J. Transl Sci. 1, 1 (2015).
7. Gertler, R. et al. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent. Results. Cancer. Res. 162, 149-155 (2003).
8. Sun, Y. F. et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma afer curative resection. Hepatology. 57, 1458-1468 (2013).
9. Rodriguez-Peralvarez, M. et al. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann. Surg. Oncol. 20, 325-339 (2013).
10. Lim, K. C. et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann. Surg. 254, 108-113 (2015).
11. Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580-584 (2013).
12. Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer. Res. 38, 2651-2660 (1978).
13. Riethdorf, S. & Pantel, K. Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells. Ann. NY. Acad. Sci. 1210, 66-77 (2010).
14. Lopez-Riquelme, N. et al. Imaging cytometry for counting circulating tumor cells: comparative analysis of the CellSearch vs. ImageStream systems. APMIS. 121, 1139-1143 (2013).
15. Bruix, J. & Sherman, M. Management of hepatocellular carcinoma. Hepatology. 42, 1208-1236 (2005).
16. Cong, W. M. et al. Evidence-based practice guidelines for standardized pathological diagnosis of primary liver cancer in China: 2015. Chinese. Journal. of Hepatology. 23, 321-327 (2015).